<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_choline" title="Plasma Kinetics of Choline and Choline Metabolites After A Single Dose of SuperbaBoostTM Krill Oil or Choline Bitartrate in Healthy Volunteers" shortTitle="choline" author="Yvonne Mödinger, Christiane Schön, Manfred Wilhelm, Petter-Arnt Hals" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2072-6643/11/10/2548/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
4.	NNP	4.
</s>
<s type="frag">
Discussion	NN	discussion
</s>
</head>
<p>
<s type="decl">
In	IN	in
the	DT	the
present	JJ	present
study	NN	study
,	,	,
the	DT	the
absorption	NN	absorption
pattern	NN	pattern
and	CC	and
pharmacokinetic	JJ	pharmacokinetic
pattern	NN	pattern
of	IN	of
free	JJ	free
choline	NN	choline
from	IN	from
Superba	NNP	Superba
<hi rend="italic">
Boost	NNP	Boost
</hi>
TM	NNP	TM
krill	NN	krill
oil	NN	oil
and	CC	and
choline	NN	choline
bitartrate	NN	bitartrate
were	VBD	be
investigated	VBN	investigate
.	.	.
</s>
<s type="decl">
In	IN	in
Superba	NNP	Superba
<hi rend="italic">
Boost	NNP	Boost
</hi>
TM	NNP	TM
,	,	,
choline	NN	choline
is	VBZ	be
bound	VBN	bind
in	IN	in
a	DT	a
lipid-soluble	JJ	lipid-soluble
form	NN	form
as	IN	as
phosphatidylcholine	NN	phosphatidylcholine
,	,	,
while	IN	while
it	PRP	it
is	VBZ	be
present	JJ	present
as	IN	as
a	DT	a
water-soluble	JJ	water-soluble
salt	NN	salt
structure	NN	structure
in	IN	in
choline	NN	choline
bitartrate	NN	bitartrate
.	.	.
</s>
<s type="decl">
Results	NNS	result
show	VBP	show
that	IN	that
free	JJ	free
choline	NN	choline
levels	NNS	level
in	IN	in
plasma	NN	plasma
were	VBD	be
comparable	JJ	comparable
between	IN	between
Superba	NNP	Superba
<hi rend="italic">
Boost	NNP	Boost
</hi>
TM	NNP	TM
and	CC	and
choline	NN	choline
bitartrate	NN	bitartrate
,	,	,
but	CC	but
peak	NN	peak
choline	NN	choline
concentrations	NNS	concentration
were	VBD	be
reached	VBN	reach
significantly	RB	significantly
later	RBR	late
upon	IN	upon
intake	NN	intake
of	IN	of
Superba	NNP	Superba
<hi rend="italic">
Boost	NNP	Boost
</hi>
TM	NNP	TM
compared	VBN	compare
to	IN	to
choline	NN	choline
bitartrate	NN	bitartrate
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
levels	NNS	level
of	IN	of
the	DT	the
choline	NN	choline
metabolites	NNS	metabolite
betaine	NN	betaine
and	CC	and
DMG	NNP	DMG
were	VBD	be
higher	JJR	high
,	,	,
while	IN	while
levels	NNS	level
of	IN	of
TMAO	NNP	TMAO
were	VBD	be
lower	JJR	low
upon	IN	upon
intake	NN	intake
of	IN	of
Superba	NNP	Superba
<hi rend="italic">
Boost	NNP	Boost
</hi>
TM	NNP	TM
compared	VBN	compare
to	IN	to
choline	NN	choline
bitartrate	NN	bitartrate
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
dependency	NN	dependency
between	IN	between
choline	NN	choline
intake	NN	intake
and	CC	and
circulating	VBG	circulate
levels	NNS	level
of	IN	of
free	JJ	free
choline	NN	choline
and	CC	and
its	PRP$	its
metabolites	NNS	metabolite
is	VBZ	be
concealed	VBN	conceal
by	IN	by
homeostatic	JJ	homeostatic
regulations	NNS	regulation
and	CC	and
rapid	JJ	rapid
tissue	NN	tissue
uptake	NN	uptake
.	.	.
</s>
<s type="decl">
Thus	RB	thus
,	,	,
concentrations	NNS	concentration
of	IN	of
choline	NN	choline
and	CC	and
its	PRP$	its
metabolites	NNS	metabolite
are	VBP	be
usually	RB	usually
within	IN	within
a	DT	a
narrow	JJ	narrow
range	NN	range
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
literature	NN	literature
,	,	,
endogenous	JJ	endogenous
free	JJ	free
fasting	NN	fasting
choline	NN	choline
levels	NNS	level
under	IN	under
physiological	JJ	physiological
conditions	NNS	condition
range	VBP	range
between	IN	between
7	CD	7
–	SYM	-
12	CD	12
µmol/L	NN	µmol/L
,	,	,
which	WDT	which
could	MD	could
be	VB	be
confirmed	VBN	confirm
in	IN	in
the	DT	the
present	JJ	present
study	NN	study
with	IN	with
a	DT	a
mean	JJ	mean
choline	NN	choline
concentration	NN	concentration
of	IN	of
9.6	CD	9.6
µmol/L	NN	µmol/L
before	IN	before
product	NN	product
intake	NN	intake
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
baseline	NN	baseline
values	NNS	value
were	VBD	be
highly	RB	highly
comparable	JJ	comparable
within	IN	within
all	DT	all
groups	NNS	group
and	CC	and
within	IN	within
the	DT	the
two	CD	2
kinetic	JJ	kinetic
days	NNS	day
.	.	.
</s>
</p>
<p>
<s type="decl">
It	PRP	it
is	VBZ	be
well	RB	well
known	VBN	know
that	IN	that
choline	NN	choline
levels	NNS	level
are	VBP	be
influenced	VBN	influence
by	IN	by
nutrition	NN	nutrition
,	,	,
and	CC	and
choline	NN	choline
sources	NNS	source
depend	VBP	depend
on	IN	on
the	DT	the
diet	NN	diet
,	,	,
In	IN	in
a	DT	a
normal	JJ	normal
Western	JJ	Western
diet	NN	diet
,	,	,
choline	NN	choline
can	MD	can
be	VB	be
obtained	VBN	obtain
from	IN	from
eggs	NNS	egg
,	,	,
liver	NN	liver
,	,	,
soybeans	NNS	soybean
and	CC	and
pork	NN	pork
,	,	,
where	WRB	where
choline	NN	choline
is	VBZ	be
present	JJ	present
primarily	RB	primarily
as	IN	as
phosphatidylcholine	NN	phosphatidylcholine
.	.	.
</s>
<s type="decl">
It	PRP	it
was	VBD	be
shown	VBN	show
that	IN	that
the	DT	the
consumption	NN	consumption
of	IN	of
a	DT	a
small	JJ	small
breakfast	NN	breakfast
led	VBD	lead
to	IN	to
25	CD	25
–	SYM	-
30	CD	30
%	NN	%
higher	JJR	high
choline	NN	choline
levels	NNS	level
compared	VBN	compare
to	IN	to
the	DT	the
fasting	NN	fasting
condition	NN	condition
,	,	,
and	CC	and
that	IN	that
a	DT	a
high	JJ	high
choline-containing	JJ	choline-containing
diet	NN	diet
resulted	VBD	result
in	IN	in
an	DT	a
up	IN	up
to	IN	to
two-fold	JJ	two-fold
increase	NN	increase
in	IN	in
plasma	NN	plasma
choline	NN	choline
.	.	.
</s>
<s type="decl">
In	IN	in
a	DT	a
recent	JJ	recent
study	NN	study
by	IN	by
Cho	NNP	Cho
et	FW	et
al.	FW	al.
,	,	,
eggs	NNS	egg
were	VBD	be
provided	VBN	provide
as	IN	as
a	DT	a
choline	NN	choline
source	NN	source
,	,	,
which	WDT	which
contained	VBD	contain
comparable	JJ	comparable
amounts	NNS	amount
of	IN	of
choline	NN	choline
(	-LRB-	(
479	CD	479
mg	NN	mgillileter
)	-RRB-	)
as	IN	as
the	DT	the
herein	RB	herein
investigated	VBN	investigate
study	NN	study
products	NNS	product
(	-LRB-	(
choline	NN	choline
bitartrate	NN	bitartrate
:	:	:
620	CD	620
mg	NN	mgillileter
;	:	;
Superba	NNP	Superba
<hi rend="italic">
Boost	NNP	Boost
</hi>
TM	NNP	TM
:	:	:
572	CD	572
mg	NNS	mgillileter
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Cho	NNP	Cho
et	FW	et
al.	FW	al.
reported	VBD	report
a	DT	a
1.6-fold	CD	1.6-fold
increase	NN	increase
in	IN	in
free	JJ	free
choline	NN	choline
after	IN	after
consumption	NN	consumption
of	IN	of
the	DT	the
egg	NN	egg
meal	NN	meal
,	,	,
in	IN	in
comparison	NN	comparison
to	IN	to
the	DT	the
fruit	NN	fruit
control	NN	control
meal	NN	meal
.	.	.
</s>
<s type="decl">
Correspondingly	RB	correspondingly
,	,	,
the	DT	the
choline	NN	choline
increase	NN	increase
in	IN	in
the	DT	the
current	JJ	current
study	NN	study
upon	IN	upon
supplement	NN	supplement
intake	NN	intake
was	VBD	be
comparable	JJ	comparable
(	-LRB-	(
choline	NN	choline
bitartrate	NN	bitartrate
:	:	:
1.35-fold	CD	1.35-fold
;	:	;
Superba	NNP	Superba
<hi rend="italic">
Boost	NN	boost
</hi>
TM	NNP	TM
:	:	:
1.48-fold	CD	1.48-fold
)	-RRB-	)
.	.	.
</s>
</p>
<p>
<s type="decl">
To	TO	to
control	VB	control
for	IN	for
confounding	VBG	confound
factors	NNS	factor
of	IN	of
food	NN	food
,	,	,
subjects	NNS	subject
of	IN	of
the	DT	the
present	JJ	present
study	NN	study
adhered	VBD	adhere
to	IN	to
a	DT	a
diet	NN	diet
low	JJ	low
in	IN	in
choline	NN	choline
three	CD	3
days	NNS	day
before	IN	before
the	DT	the
study	NN	study
intervention	NN	intervention
and	CC	and
consumed	VBD	consume
standardized	VBN	standardize
meals	NNS	meal
during	IN	during
the	DT	the
kinetic	JJ	kinetic
days	NNS	day
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
a	DT	a
parallel	JJ	parallel
study	NN	study
arm	NN	arm
was	VBD	be
included	VBN	include
,	,	,
whose	WP$	whose
subjects	NNS	subject
underwent	VBD	undergo
a	DT	a
single	JJ	single
kinetic	JJ	kinetic
dose	NN	dose
after	IN	after
the	DT	the
intake	NN	intake
of	IN	of
fish	NN	fish
oil	NN	oil
as	IN	as
a	DT	a
placebo	NN	placebo
control	NN	control
that	WDT	that
was	VBD	be
devoid	JJ	devoid
of	IN	of
choline	NN	choline
.	.	.
</s>
<s type="decl">
Of	IN	of
note	NN	note
,	,	,
we	PRP	we
observed	VBD	observe
a	DT	a
minor	JJ	minor
increase	NN	increase
in	IN	in
choline	NN	choline
levels	NNS	level
in	IN	in
the	DT	the
placebo	NN	placebo
group	NN	group
after	IN	after
the	DT	the
4	CD	4
h	NN	hour
time	NN	time
point	NN	point
;	:	;
thus	RB	thus
,	,	,
the	DT	the
standardized	VBN	standardize
lunch	NN	lunch
served	VBN	serve
after	IN	after
four	CD	4
hours	NNS	hour
could	MD	could
have	VB	have
contributed	VBN	contribute
to	IN	to
this	DT	this
elevation	NN	elevation
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
no	DT	no
such	JJ	such
effect	NN	effect
was	VBD	be
seen	VBN	see
in	IN	in
the	DT	the
study	NN	study
groups	NNS	group
receiving	VBG	receive
choline	NN	choline
supplements	NNS	supplement
.	.	.
</s>
<s type="decl">
In	IN	in
addition	NN	addition
,	,	,
by	IN	by
implementing	VBG	implement
the	DT	the
control	NN	control
group	NN	group
,	,	,
we	PRP	we
were	VBD	be
able	JJ	able
to	TO	to
exclude	VB	exclude
possible	JJ	possible
circadian	NN	circadian
rhythm-dependent	NN	rhythm-dependent
variations	NNS	variation
in	IN	in
choline	NN	choline
levels	NNS	level
,	,	,
in	IN	in
contrast	NN	contrast
to	IN	to
Park	NNP	Park
et	FW	et
al.	FW	al.
,	,	,
who	WP	who
observed	VBD	observe
a	DT	a
slight	JJ	slight
elevation	NN	elevation
of	IN	of
free	JJ	free
choline	NN	choline
levels	NNS	level
in	IN	in
the	DT	the
afternoon	NN	afternoon
during	IN	during
a	DT	a
12	CD	12
h-lasting	NN	h-lasting
observation	NN	observation
of	IN	of
endogenous	JJ	endogenous
choline	NN	choline
levels	NNS	level
.	.	.
</s>
</p>
<p>
<s type="decl">
Krill	NNP	Krill
oil	NN	oil
is	VBZ	be
increasingly	RB	increasingly
recognized	VBN	recognize
as	IN	as
a	DT	a
useful	JJ	useful
source	NN	source
of	IN	of
phosphatidylcholine	NN	phosphatidylcholine
,	,	,
in	IN	in
addition	NN	addition
to	IN	to
its	PRP$	its
acknowledged	VBN	acknowledge
role	NN	role
in	IN	in
providing	VBG	provide
the	DT	the
omega-3	NN	omega-3
fatty	JJ	fatty
acids	NNS	acid
EPA	NNP	EPA
and	CC	and
DHA	NNP	DHA
.	.	.
</s>
<s type="decl">
In	IN	in
a	DT	a
former	JJ	former
study	NN	study
,	,	,
phosphatidylcholine	NN	phosphatidylcholine
was	VBD	be
shown	VBN	show
to	TO	to
raise	VB	raise
plasma	NN	plasma
choline	NN	choline
levels	NNS	level
more	RBR	more
efficiently	RB	efficiently
compared	VBN	compare
to	IN	to
ingestion	NN	ingestion
of	IN	of
free	JJ	free
choline	NN	choline
as	IN	as
choline	NN	choline
chloride	NN	chloride
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
current	JJ	current
study	NN	study
we	PRP	we
observed	VBD	observe
a	DT	a
significant	JJ	significant
increase	NN	increase
of	IN	of
choline	NN	choline
after	IN	after
single	JJ	single
doses	NNS	dose
of	IN	of
both	CC	both
phosphatidylcholine	NN	phosphatidylcholine
and	CC	and
the	DT	the
reference	NN	reference
product	NN	product
choline	NN	choline
bitartrate	NN	bitartrate
;	:	;
however	RB	however
,	,	,
phosphatidylcholine	NN	phosphatidylcholine
was	VBD	be
not	RB	not
more	RBR	more
efficient	JJ	efficient
,	,	,
since	IN	since
there	EX	there
were	VBD	be
no	DT	no
significant	JJ	significant
differences	NNS	difference
in	IN	in
the	DT	the
pharmacokinetic	JJ	pharmacokinetic
endpoints	NNS	endpoint
AUC	NNP	AUC
and	CC	and
Cmax	NNP	Cmax
.	.	.
</s>
<s type="sub">
This	DT	this
discrepancy	NN	discrepancy
compared	VBN	compare
to	IN	to
the	DT	the
former	JJ	former
study	NN	study
could	MD	could
be	VB	be
due	JJ	due
to	IN	to
possible	JJ	possible
differences	NNS	difference
in	IN	in
the	DT	the
bioavailability	NN	bioavailability
of	IN	of
the	DT	the
chosen	VBN	choose
choline	NN	choline
salts	NNS	salt
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
to	IN	to
the	DT	the
best	NN	best
of	IN	of
our	PRP$	our
knowledge	NN	knowledge
,	,	,
choline	NN	choline
bitartrate	NN	bitartrate
and	CC	and
choline	NN	choline
chloride	NN	chloride
bioavailability	NN	bioavailability
has	VBZ	have
not	RB	not
been	VBN	be
directly	RB	directly
compared	VBN	compare
to	IN	to
date	NN	date
.	.	.
</s>
<s type="decl">
Still	RB	still
,	,	,
the	DT	the
uptake	NN	uptake
profile	NN	profile
of	IN	of
free	JJ	free
choline	NN	choline
in	IN	in
the	DT	the
current	JJ	current
study	NN	study
indicated	VBD	indicate
a	DT	a
slower	JJR	slow
increase	NN	increase
upon	IN	upon
phosphatidylcholine	NN	phosphatidylcholine
(	-LRB-	(
Superba	NNP	Superba
<hi rend="italic">
Boost	NNP	Boost
</hi>
TM	NNP	TM
)	-RRB-	)
intake	NN	intake
compared	VBN	compare
to	IN	to
choline	NN	choline
bitartrate	NN	bitartrate
.	.	.
</s>
<s type="decl">
This	DT	this
difference	NN	difference
in	IN	in
Tmax	NNP	Tmax
between	IN	between
the	DT	the
study	NN	study
products	NNS	product
could	MD	could
result	VB	result
from	IN	from
the	DT	the
structural	JJ	structural
differences	NNS	difference
between	IN	between
the	DT	the
choline	NN	choline
forms	NNS	form
and	CC	and
from	IN	from
the	DT	the
associated	VBN	associate
differences	NNS	difference
in	IN	in
absorption	NN	absorption
and	CC	and
metabolism	NN	metabolism
.	.	.
</s>
<s type="decl">
Phosphatidylcholine	NN	Phosphatidylcholine
and/or	CC	and/or
its	PRP$	its
isoforms	NNS	isoform
may	MD	may
be	VB	be
absorbed	VBN	absorb
intact	JJ	intact
and	CC	and
can	MD	can
also	RB	also
be	VB	be
hydrolyzed	VBN	hydrolyze
into	IN	into
phosphatidic	JJ	phosphatidic
acid	NN	acid
and	CC	and
free	JJ	free
choline	NN	choline
by	IN	by
phospholipase	NN	phospholipase
D.	NN	D.
Due	JJ	due
to	IN	to
this	DT	this
conversion	NN	conversion
step	NN	step
,	,	,
it	PRP	it
supposedly	RB	supposedly
takes	VBZ	take
longer	NN	long
to	TO	to
obtain	VB	obtain
free	JJ	free
choline	NN	choline
from	IN	from
phosphatidylcholine	NN	phosphatidylcholine
compared	VBN	compare
to	IN	to
choline	NN	choline
bitartrate	NN	bitartrate
,	,	,
where	WRB	where
free	JJ	free
choline	NN	choline
from	IN	from
the	DT	the
salt	NN	salt
structure	NN	structure
is	VBZ	be
more	RBR	more
rapidly	RB	rapidly
available	JJ	available
.	.	.
</s>
<s type="decl">
Our	PRP$	our
findings	NNS	finding
are	VBP	be
in	IN	in
agreement	NN	agreement
with	IN	with
former	JJ	former
findings	NNS	finding
showing	VBG	show
that	IN	that
choline	NN	choline
levels	NNS	level
after	IN	after
choline	NN	choline
chloride	NN	chloride
reached	VBD	reach
peak	NN	peak
levels	NNS	level
earlier	RBR	early
and	CC	and
were	VBD	be
reduced	VBN	reduce
to	IN	to
baseline	NN	baseline
earlier	RBR	early
than	IN	than
after	IN	after
phosphatidylcholine	NN	phosphatidylcholine
intake	NN	intake
,	,	,
where	WRB	where
levels	NNS	level
remained	VBD	remain
elevated	VBN	elevate
for	IN	for
12	CD	12
h.	NNS	h.
</s>
</p>
</text>